Nahdi Medical Company

4164.SRSAUHealthcare● Active

$95.40

$-0.10(-0.10%)

Market Cap$12.4B

P/E Ratio—

52W High$132.1

52W Low$91

Avg Volume138K

Open$95.95

Beta0.12

Overview

Nahdi Medical Company (4164.SR) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

4164.SR · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$555.9M▼ -41.9% vs prior year

FY · as of Dec 31, 2025 · Reported in SAR

Cash & Cash Equiv. (CCE)

$554.4M

cashAndCashEquivalents

Short-Term Investments

$1.5M

shortTermInvestments

YoY Change vs Prior Year

-41.9%

vs prior fiscal year

Latest Quarter

$1.22B

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in SAR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$555.9MCash on Hand

Total Debt$1.78BTotal Debt

Net Cash / Net Debt−$1.23BNet Debt Position

Cash vs Debt Ratio

Cash 24%Nahdi Medical Company cash as % of market cap: 4.48%% · MCap $12BDebt 76%

Nahdi Medical Company carries a net debt position of $1.23B. Total debt ($1.78B) exceeds cash on hand ($555.9M). Nahdi Medical Company cash vs debt ratio: 24% cash / 76% debt.

Net Cash = Cash & ST Investments − Total Debt$555.9M − $1.78B = −$1.23B

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

4164.SR annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

4164.SR cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$555.9M-41.9%

Dec 31, 2024FY$956.8M+5.2%

Dec 31, 2023FY$909.7M-15.5%

Dec 31, 2022FY$1.08B+168.4%

Dec 31, 2021FY$401.0M-60.2%

4164.SR cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

4164.SR vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Nahdi Medical CompanyYOU

4164.SR

$555.9M$12B4.5%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Nahdi Medical Company (4164.SR) cash on hand as of December 31, 2025 is $555.9M, comprising $554.4M in cash and cash equivalents (CCE) plus $1.5M in short-term investments — reported as Nahdi Medical Company cash and short-term investments on the balance sheet (10-K filing). Also referred to as Nahdi Medical Company cash reserves or cash position.

Nahdi Medical Company annual cash on hand history shows decreased -41.9% in 2025: decreased -41.9% in 2025. Nahdi Medical Company cash reserves in 2025 reflect the company's capital allocation strategy.

Nahdi Medical Company carries total debt of $1.78B against cash of $555.9M, resulting in a net debt position of -$1.23B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

4164.SR cash on hand · 5 questions

As of December 31, 2025, Nahdi Medical Company (4164.SR) has $555,903,228 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $554,443,212 in cash and cash equivalents (CCE) plus $1,460,016 in short-term investments. Latest quarter (March 31, 2026): $1.22B. Data sourced from the annual 10-K filing via FMP.

4164.SR cash on hand4164.SR cash reserves4164.SR cash 2025how much cash does 4164.SR have

▸ Source: FMP /balance-sheet-statement · US GAAP · Nahdi Medical Company · Nahdi Medical Company SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025